MedTrace Logo

Multi-country, Multi-center Cohort Study of Anti-Mullerian Hormone Profile in Asia Pacific Infertile Patients

NCT04203355 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2019-12-23

No results posted yet for this study

Summary

This study is to detect the infertile couple (women) Anti-Mullerian Hormone (AMH) profile in major subgroups such as Poly Cystic Ovarian Syndrome (PCOS), Endometriosis, etc via age intervals and ethnic difference.

Conditions

Sponsors & Collaborators

  • Taipei Medical University

    lead OTHER

Principal Investigators

  • Chii-Ruey Tzeng, MD, Ph.D · Taipei Medical University Hospital

Eligibility

Min Age
20 Years
Max Age
43 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2020-12-31
Completion
2021-05-31

Countries

  • China
  • Hong Kong
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04203355 on ClinicalTrials.gov